- Home
- WERN vs BHC Comparison
WERN vs BHC Comparison
Compare WERN & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WERN | BHC |
|---|---|---|
| Founded | 1956 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | WERN | BHC |
|---|---|---|
| Price | $40.44 | $4.77 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 14 | 3 |
| Target Price | ★ $33.79 | $8.00 |
| AVG Volume (30 Days) | 910.2K | ★ 2.0M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | $2,974,396,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $22.24 | $4.61 |
| Revenue Next Year | $6.33 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.06 | $4.57 |
| 52 Week High | $45.27 | $8.69 |
Technical Indicators
Market Signals| Indicator | WERN | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 48.56 | 32.10 |
| Support Level | $30.30 | N/A |
| Resistance Level | $45.27 | $6.31 |
| Average True Range (ATR) | 1.55 | 0.21 |
| MACD | -0.61 | -0.04 |
| Stochastic Oscillator | 13.06 | 21.51 |
Price Performance
Historical ComparisonAbout WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company engaged in transporting truckload shipments of general commodities in both interstate and intrastate commerce. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.